U Researchers Seek Women for Herpes Vaccine Study

U Researchers Seek Women for Herpes Vaccine Study

The University of Utah School of Medicine's Division of Infectious Diseases is looking for women ages 18-30 to take part in a National Institutes of Health-sponsored herpes vaccine study.

The U medical school is one of 25 centers nationwide participating in the randomized, double-blind study of a herpes simplex virus (HSV) glycoprotein D vaccine for the prevention of HSV-2 infection. The vaccine is not a live virus; so there is no chance the vaccine itself will give participants herpes.

One group of participants will receive the new vaccine, while a control group will receive the hepatitis A vaccine. Women who are pregnant, breast-feeding, or who have a history of cold sores, genital herpes, hepatitis A, or hepatitis A vaccination are not eligible to participate.

All potential participants will have a blood-screening sample taken for herpes simplex virus type-specific serology, which must be negative.

Patients will be compensated for their time. The study is being performed on the University campus.